Kenneth R. Chien
31Patents
9h-index
45Co-inventors
75Inventor score
Filing activity: Apr 25, 1994 → Oct 21, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5534615A | Cardiac hypertrophy factor and uses therefor | Emerging Cross-Sectional Technologies | 115 | Expired |
| US7745113B2 | Use of islet 1 as a marker for isolating or generating stem cells | Chemistry; Metallurgy | 24 | Expired |
| US5571893A | Cardiac hypertrophy factor | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6451594B1 | Recombinant adenovirus for tissue specific expression in heart | Chemistry; Metallurgy | 17 | Expired |
| US5571675A | Detection and amplification of candiotrophin-1(cardiac hypertrophy factor) | Emerging Cross-Sectional Technologies | 15 | Expired |
| US5624806A | Antibodies to cardiac hypertrophy factor and uses thereof | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5723585A | Method of purifying cardiac hypertrophy factor | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5627073A | Hybridomas producing antibodies to cardiac hypertrophy factor | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5679545A | Gene encoding cardiac hypertrophy factor | Emerging Cross-Sectional Technologies | 13 | Expired |
| US8765117B2 | Generation of vascularized human heart tissue and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US5968981A | Retinoid suppression of ventricular muscle cell hypertrophy | Physics | 5 | Expired |
| US10597637B2 | Use of jagged 1/frizzled 4 as a cell surface marker for isolating human cardiac ventricular progenitor cells | Chemistry; Metallurgy | 4 | Active |
| US10612094B2 | Genetic markers for engraftment of human cardiac ventricular progenitor cells | Chemistry; Metallurgy | 4 | Active |
| US10596200B2 | Use of LIFR or FGFR3 as a cell surface marker for isolating human cardiac ventricular progenitor cells | Chemistry; Metallurgy | 4 | Active |
| US10508263B2 | Methods for isolating human cardiac ventricular progenitor cells | Chemistry; Metallurgy | 4 | Active |
| US11186820B2 | Use of Neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cells | Chemistry; Metallurgy | 3 | Active |
| US5767155A | Retinoid suppression of ventricular muscle cell hypertrophy | Performing Operations; Transporting | 3 | Expired |
| US6306826A | Treatment of heart failure with growth hormone | Human Necessities | 2 | Expired |
| US11401508B2 | Methods for isolating human cardiac ventricular progenitor cells | Chemistry; Metallurgy | 2 | Active |
| US6221618A | Retinoid suppression of ventricular muscle cell hypertrophy | Physics | 2 | Expired |
| US10086043B2 | Efficient protein expression in vivo using modified RNA (MOD-RNA) | Chemistry; Metallurgy | 1 | Active |
| US7193075B2 | Sequences upstream of the CARP gene, vectors containing them and uses thereof | Chemistry; Metallurgy | 1 | Expired |
| US7399750B2 | Methods for cardiac gene transfer | Chemistry; Metallurgy | 1 | Expired |
| US11725244B2 | Genetic markers for engraftment of human cardiac ventricular progenitor cells | Chemistry; Metallurgy | 1 | Active |
| US6278040A | Receptor-deficient mice and cell lines derived therefrom, and uses thereof | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.